SavedAdd your journal

Journals / Mucosa / 2022 / Cilt: 5 Sayı: 2

Prognosis and treatment of COVID-19 infection while receiving treatment for comorbid active tuberculosis: report of two cases

Aktif tüberküloz tedavisi sırasında gelişen COVID-19 enfeksiyonunun tedavi ve prognozu: İki olgu sunumu

Yelda Varol(UNIVERSITY OF HEALTH SCIENCES, İZMİR DR. SUAT SEREN HEALTH RESEARCH CENTER FOR PULMONOLOGY AND THORACIC SURGERY)0000-0003-4604-7173
Hilal Özdemir Demirci(UNIVERSITY OF HEALTH SCIENCES, İZMİR DR. SUAT SEREN HEALTH RESEARCH CENTER FOR PULMONOLOGY AND THORACIC SURGERY)0000-0003-4643-7438
Onur Karaman(UNIVERSITY OF HEALTH SCIENCES, İZMİR DR. SUAT SEREN HEALTH RESEARCH CENTER FOR PULMONOLOGY AND THORACIC SURGERY)0000-0002-4384-3732
Tülay Akarca(UNIVERSITY OF HEALTH SCIENCES, İZMİR DR. SUAT SEREN HEALTH RESEARCH CENTER FOR PULMONOLOGY AND THORACIC SURGERY)0000-0001-8781-4485
Diğdem Özbakır(UNIVERSITY OF HEALTH SCIENCES, İZMİR DR. SUAT SEREN HEALTH RESEARCH CENTER FOR PULMONOLOGY AND THORACIC SURGERY)0000-0002-3179-5235
Journal
Mucosa
Pages
51–55
Publication Date
2022-09-30
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This case report details the diagnostic and treatment stages of two patients who had active tuberculosis and COVID-19 infection, as well as the outcomes of their therapies, both of which were effective.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Tuberculosis is still a serious public health issue in underdeveloped countries.
📊
Key Findings & Data:There is presently little clinical experience with the co-existence of tuberculosis and COVID-19 infection, presented as the severe acute respiratory syndrome coronavirus 2 infection, which was first observed in China in December 2019.
💡
Conclusion & Impact:This case report details the diagnostic and treatment stages of two patients who had active tuberculosis and COVID-19 infection, as well as the outcomes of their therapies, both of which were effective.
🔬Design:Olgu Sunumu
📍Scope:2019 Verileri
⚙️Variables:tüberküloz · covid-19 · koenfeksiyon

Abstract

Tuberculosis is still a serious public health issue in underdeveloped countries. There is presently little clinical experience with the co-existence of tuberculosis and COVID-19 infection, presented as the severe acute respiratory syndrome coronavirus 2 infection, which was first observed in China in December 2019. This case report details the diagnostic and treatment stages of two patients who had active tuberculosis and COVID-19 infection, as well as the outcomes of their therapies, both of which were effective.

Özet

Tüberküloz, az gelişmiş ülkelerde hala ciddi bir halk sağlığı sorunudur. Tüberküloz ve COVID-19 enfeksiyonunun birlikteliği ile ilgili çok az sayıda klinik deneyim mevcuttur. COVID-19 enfeksiyonu ilk kez şiddetli akut solunum sendromu tablosu olarak Çin’de Aralık 2019’da görülmüştür. Bu raporda aktif tüberkülozu ve COVID-19 enfeksiyonu olan iki hastanın tanı ve başarılı olan tedavi aşamaları detaylı olarak sunulmuştur.

🔖

Cite This Article

Varol, Y., Demirci, H. Ö., Karaman, O., Akarca, T., Özbakır, D. (2022). Prognosis and treatment of COVID-19 infection while receiving treatment for comorbid active tuberculosis: report of two cases. Mucosa, Cilt: 5 Sayı: 2, 51–55. https://doi.org/10.33204/mucosa.1115584

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. World Health Organization. Global tuberculosis report 2020.
  2. https://www.who.int/emergencies/diseases/novelcoronavirus-2019/situation-reports/ Accessed 28.09.2022.
  3. https://covid19.saglik.gov.tr/ Accessed 28.09.2022.
  4. Leung CC, Lam TH, Cheng KK. Let us not forget the mask in our attempts to stall the spread of COVID-19. Int J Tuberc Lung Dis 2020;24:364-6.
  5. Noia Maciel EL, Gonçalves Junior E, Pretti Dalcolmo MM.Tuberculosis and coronavirus: what do we know? Epidemiol Serv Saude 2020;29:e2020128.
  6. Zhang JJ, Dong X, Cao YY, et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy 2020;75:1730-41.
  7. Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese center for disease control and prevention. JAMA 2020;323:1239-42.
  8. Chen Y, Wang Y, Fleming J, et al. Active or latent tuberculosis increases susceptibility to COVID-19 and disease severity. MedrxivmedRxiv preprint. Mar. 2020. Available at: https://www.medrxiv.org/ content/10.1101/2020.03.10.20033795v1.full.pdf. Accessed 28.09.2022.
  9. Tadolini M, Codecasa LR, Garcia-Garcia JM, et al. Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases. Eur Respir J 2020;56:2001398.